Aurinia Pharmaceuticals Inc. Debt Securities, Held-to-maturity
Discontinued › Balance Sheet › Assets › Investments
us-gaap:HeldToMaturitySecurities · last filed 2024-08-01
- 2024-06-30: Debt Securities, Held-to-maturity $330.53M.
- 2024-03-31: Debt Securities, Held-to-maturity $319.96M.
- 2023-12-31: Debt Securities, Held-to-maturity $350.42M.
- 2023-09-30: Debt Securities, Held-to-maturity $338.04M.
| Period end | Debt Securities, Held-to-maturity | Debt Securities, Held-to-maturity as first filed |
|---|---|---|
| 2024-06-30 | $330.53M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $319.96M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $350.42M 10-Q · filed 2024-08-01 | |
| 2023-09-30 | $338.04M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $350.93M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $361.72M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $389.65M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $377.37M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $389.42M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $8.80M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $446.90M 10-K · filed 2023-02-28 | $19.20M 10-K · filed 2022-02-28 |
| 2021-09-30 | $21.50M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $48.50M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $89.10M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $150.40M 10-K · filed 2022-02-28 |